title: Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.
abstract: OBJECTIVE
  To compare the electrophysiological and histopathological features of immunological myasthenia gravis (MG) subtypes.
  
  
  METHODS
  Fifty MG patients underwent clinical examination, MuSK-Ab and AChR-Ab analysis. The majority underwent quantitative and single-fiber electromyography (QEMG, SFEMG), repetitive nerve stimulation and deltoid muscle biopsy. From muscle specimens with histological mitochondrial dysfunction, we amplified mitochondrial DNA (mtDNA). In specimens with mtDNA deletions, the nuclear gene POLG1 was sequenced.
  
  
  RESULTS
  Five AChR-Ab seropositive [AChR(+)] and 5 seronegative [AChR(-)] patients were MuSK-Ab seropositive [MuSK(+)]. Five of 7 neurophysiologically examined MuSK(+) patients (71%) had proximal myopathic pattern, compared to 7 of 31 MuSK(-)/AChR(+) patients (23%) (P=0.012). SFEMG was abnormal in all examined MuSK(+) patients. All 7 biopsied MuSK(+) and 32 MuSK(-) patients (89%) had cytochrome c oxidase (COX) negative fibers. Three of five MuSK(+) and 13 of 20 MuSK(-) patients analyzed had multiple mtDNA deletions but no POLG1 mutations.
  
  
  CONCLUSIONS
  Similar degree of SFEMG abnormalities was present in proximal muscles among MuSK(+) and AChR(+) patients. Proximal myopathy was over-represented in MuSK(+) patients; however, both MuSK(+) and MuSK(-) patients had mild myopathy with frequent mitochondrial abnormalities.
  
  
  CONCLUSIONS
  The weakness in MuSK(+) patients is most likely due to disturbed neuromuscular transmission. The frequently encountered mitochondrial dysfunction in MG warrants further study.
authors.affiliation: Department of Clinical Neurophysiology, University Hospital, S-75185 Uppsala, Sweden. anna.rostedt@swipnet.se
authors.forename: A
authors.initials: A
authors.lastname: Rostedt Punga
authors.forename: K
authors.initials: K
authors.lastname: Ahlqvist
authors.forename: E
authors.initials: E
authors.lastname: Bartoccioni
authors.forename: F
authors.initials: F
authors.lastname: Scuderi
authors.forename: M
authors.initials: M
authors.lastname: Marino
authors.forename: A
authors.initials: A
authors.lastname: Suomalainen
authors.forename: H
authors.initials: H
authors.lastname: Kalimo
authors.forename: E V
authors.initials: EV
authors.lastname: Stålberg
mesh_terms: D000200:Action Potentials / Q000502:physiology; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000378:metabolism; D016022:Case-Control Studies; D004272:DNA, Mitochondrial / Q000235:genetics; D004558:Electric Stimulation / Q000379:methods; D004576:Electromyography / Q000379:methods; D003576:Electron Transport Complex IV / Q000378:metabolism; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D008931:Mitochondria, Muscle / Q000276:immunology / Q000473:pathology*; D018485:Muscle Fibers, Skeletal / Q000378:metabolism / Q000473:pathology / Q000502:physiology; D018482:Muscle, Skeletal / Q000473:pathology / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D011446:Prospective Studies; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods
chemical_list: D000906:Antibodies; D004272:DNA, Mitochondrial; D007136:Immunoglobulins; D011950:Receptors, Cholinergic; D003576:Electron Transport Complex IV; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases